Pseudomonas aeruginosa PAO1 is a mesophilic human pathogen that was isolated from human, infected wound.
mesophilic human pathogen genome sequence| @ref 20215 |
Last LPSN update
2025-12-16 09:49:56 |
| Domain Pseudomonadati |
| Phylum Pseudomonadota |
| Class Gammaproteobacteria |
| Order Pseudomonadales |
| Family Pseudomonadaceae |
| Genus Pseudomonas |
| Species Pseudomonas aeruginosa |
| Full scientific name Pseudomonas aeruginosa (Schroeter 1872) Migula 1900 (Approved Lists 1980) |
| Synonyms (2) |
| @ref | Name | Growth | Medium link | Composition | |
|---|---|---|---|---|---|
| 8364 | LB (Luria-Bertani) MEDIUM (DSMZ Medium 381) | Medium recipe at MediaDive  | Name: LB (Luria-Bertani) MEDIUM (DSMZ Medium 381) Composition: Agar 20.0 g/l NaCl 10.0 g/l Tryptone 10.0 g/l Yeast extract 5.0 g/l Distilled water |
| @ref | Growth | Type | Temperature (°C) | Range | |
|---|---|---|---|---|---|
| 8364 | positive | growth | 37 | mesophilic |
| @ref | Chebi-ID | Metabolite | Utilization activity | Kind of utilization tested | |
|---|---|---|---|---|---|
| 68369 | 17128 ChEBI | adipate | + | assimilation | from API 20NE |
| 68369 | 29016 ChEBI | arginine | + | hydrolysis | from API 20NE |
| 68369 | 17634 ChEBI | D-glucose | + | assimilation | from API 20NE |
| 68369 | 17634 ChEBI | D-glucose | - | fermentation | from API 20NE |
| 68369 | 16899 ChEBI | D-mannitol | + | assimilation | from API 20NE |
| 68369 | 16024 ChEBI | D-mannose | - | assimilation | from API 20NE |
| 68369 | 27689 ChEBI | decanoate | + | assimilation | from API 20NE |
| 68369 | 4853 ChEBI | esculin | - | hydrolysis | from API 20NE |
| 68369 | 5291 ChEBI | gelatin | + | hydrolysis | from API 20NE |
| 68369 | 24265 ChEBI | gluconate | + | assimilation | from API 20NE |
| 68369 | 30849 ChEBI | L-arabinose | - | assimilation | from API 20NE |
| 68369 | 25115 ChEBI | malate | + | assimilation | from API 20NE |
| 68369 | 17306 ChEBI | maltose | - | assimilation | from API 20NE |
| 68369 | 59640 ChEBI | N-acetylglucosamine | + | assimilation | from API 20NE |
| 68369 | 17632 ChEBI | nitrate | - | reduction | from API 20NE |
| 68369 | 27897 ChEBI | tryptophan | - | energy source | from API 20NE |
| 68369 | 16199 ChEBI | urea | + | hydrolysis | from API 20NE |
Phages| @ref | Name | Strain number | |
|---|---|---|---|
| 124042 | Pseudomonas phage JG003 (Unassigned) | DSM 19880 | |
| 124042 | Pseudomonas phage JG004 (Unassigned) | DSM 19880 | |
| 124042 | Pseudomonas phage JG005 (Unassigned) | DSM 19880 | |
| 124042 | Pseudomonas phage vB_PaeM-PT-MAS01 | DSM 19880 | |
| 124042 | Pseudomonas phage vB_PaeM-PT-MAS02 | DSM 19880 | |
| 124042 | Pseudomonas phage vB_PaeM_PAO1-1 | DSM 19880 |
| @ref | Description | Assembly level | INSDC accession | NCBI tax ID | Score | |
|---|---|---|---|---|---|---|
| 124043 | 1000 assembly for Pseudomonas aeruginosa DSM 19880 | complete | GCA_050569955   | 287 | 98.92 | |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Antimicrobial Potential of Bacteriophages JG005 and JG024 Against Pseudomonas aeruginosa Isolates from Canine Otitis. | Lourenco MR, Cunha E, Tavares L, Oliveira M. | Vet Sci | 10.3390/vetsci12070646 | 2025 | | |
| Ceragenins exhibit bactericidal properties that are independent of the ionic strength in the environment mimicking cystic fibrosis sputum. | Sklodowski K, Suprewicz L, Chmielewska-Deptula SJ, Kaliniak S, Okla S, Zakrzewska M, Minarowski L, Mroz R, Daniluk T, Savage PB, Fiedoruk K, Bucki R. | Front Microbiol | 10.3389/fmicb.2023.1290952 | 2023 | | |
| Establishing an experimental Pseudomonas aeruginosa keratitis model in mice - Challenges and solutions. | Englisch CN, Wadood NA, Patzold L, Gallagher A, Krasteva-Christ G, Becker SL, Bischoff M. | Ann Anat | 10.1016/j.aanat.2023.152099 | 2023 | | |
| Commercially available antiseptics show high in vitro efficacy against pathogens most commonly associated with canine and feline infectious keratitis | Wolff H, Piroth A, Oltmanns H, Meissner J, Verspohl J, Volk H, Busse C. | Front Vet Sci | 2025 | | ||
| Systematic bacteriophage selection for the lysis of multiple Pseudomonas aeruginosa strains. | Rieper F, Wittmann J, Bunk B, Sproer C, Hafner M, Willy C, Musken M, Ziehr H, Korf IHE, Jahn D. | Front Cell Infect Microbiol | 10.3389/fcimb.2025.1597009 | 2025 | | |
| Impact of non-nutritive sweeteners on bacterial quorum sensing and phenotypic expression: implications for gut microbiome dynamics. | Watawana M, Lima EMF, Quecan BXV, Sherry M, Granato D, Schmalenberger A, Hoffmann C, Pinto UM, Hoffmann Sarda FA. | Gut Microbiome (Camb) | 10.1017/gmb.2025.10006 | 2025 | | |
| Bacteriophage-loaded functional nanofibers for treatment of P. aeruginosa and S. aureus wound infections. | Kielholz T, Rohde F, Jung N, Windbergs M. | Sci Rep | 10.1038/s41598-023-35364-5 | 2023 | | |
| Measurement of Bacterial Headspaces by FT-IR Spectroscopy Reveals Distinct Volatile Organic Compound Signatures. | Zenner C, Hall LJ, Roy S, Hauer J, Sroka R, Maiti KS. | Anal Chem | 10.1021/acs.analchem.4c02899 | 2025 | | |
| In Vitro Antimicrobial Activity of N-Acetylcysteine against Pathogens Most Commonly Associated with Infectious Keratitis in Dogs and Cats. | Walter H, Verspohl J, Meissner J, Oltmanns H, Geks AK, Busse C. | Antibiotics (Basel) | 10.3390/antibiotics12030559 | 2023 | | |
| Phage Biocontrol of Pseudomonas aeruginosa in Water. | Kauppinen A, Siponen S, Pitkanen T, Holmfeldt K, Pursiainen A, Torvinen E, Miettinen IT. | Viruses | 10.3390/v13050928 | 2021 | | |
| Laser-assisted microbial culturomics. | Qu T, Koch L, Mukherjee R, Tu Y, Seidel AL, Puttmann LD, Winkel A, Yang I, Grischke J, Liu D, Wolkers WF, Kittler S, Chichkov B, Stiesch M, Szafranski SP. | Nat Commun | 10.1038/s41467-025-66804-7 | 2025 | | |
| Adjunctive phage therapy improves antibiotic treatment of ventilator-associated-pneumonia with Pseudomonas aeruginosa. | Weissfuss C, Li J, Behrendt U, Hoffmann K, Burkle M, Tan C, Krishnamoorthy G, Korf IHE, Rohde C, Gaborieau B, Debarbieux L, Ricard JD, Witzenrath M, Felten M, Nouailles G. | Nat Commun | 10.1038/s41467-025-59806-y | 2025 | | |
| Tetramerization is essential for the enzymatic function of the Pseudomonas aeruginosa virulence factor UDP-glucose pyrophosphorylase. | Dirr L, Cleeves S, Ramon Roth I, Li L, Fiebig T, Ve T, Haussler S, Braun A, von Itzstein M, Fuhring JI. | mBio | 10.1128/mbio.02114-23 | 2024 | | |
| Chemical Profiling, Bioactive Properties, and Anticancer and Antimicrobial Potential of Juglans regia L. Leaves. | Zurek N, Pycia K, Pawlowska A, Potocki L, Kapusta IT. | Molecules | 10.3390/molecules28041989 | 2023 | | |
| Enzymology | Bacteriophage-Based Biosensing of Pseudomonas aeruginosa: An Integrated Approach for the Putative Real-Time Detection of Multi-Drug-Resistant Strains. | Harada LK, Junior WB, Silva EC, Oliveira TJ, Moreli FC, Junior JMO, Tubino M, Vila MMDC, Balcao VM. | Biosensors (Basel) | 10.3390/bios11040124 | 2021 | |
| Pathogenicity | Bacteriophage Treatment before Chemical Disinfection Can Enhance Removal of Plastic-Surface-Associated Pseudomonas aeruginosa. | Stachler E, Kull A, Julian TR. | Appl Environ Microbiol | 10.1128/aem.00980-21 | 2021 | |
| Spotlight on alternative frame coding: Two long overlapping genes in Pseudomonas aeruginosa are translated and under purifying selection. | Kreitmeier M, Ardern Z, Abele M, Ludwig C, Scherer S, Neuhaus K. | iScience | 10.1016/j.isci.2022.103844 | 2022 | | |
| A Novel Nucleic Lateral Flow Assay for Screening phaR-Containing Bacillus spp. | Wint NY, Han KK, Yamprayoonswat W, Ruangsuj P, Mangmool S, Promptmas C, Yasawong M. | J Microbiol Biotechnol | 10.4014/jmb.1907.07045 | 2019 | | |
| Nanoantibiotics: Functions and Properties at the Nanoscale to Combat Antibiotic Resistance. | Mamun MM, Sorinolu AJ, Munir M, Vejerano EP. | Front Chem | 10.3389/fchem.2021.687660 | 2021 | | |
| Bioactive Compounds and In Vitro Health-Promoting Activity of the Fruit Skin and Flesh of Different Haskap Berry (Lonicera caerulea var. kamtschatica Sevast.) Cultivars. | Zurek N, Pluta S, Swieca M, Potocki L, Seliga L, Kapusta I. | Int J Mol Sci | 10.3390/ijms26146618 | 2025 | | |
| Polyether Ionophore Antibiotics Target Drug-Resistant Clinical Isolates, Persister Cells, and Biofilms. | Wollesen M, Mikkelsen K, Tvilum MS, Vestergaard M, Wang M, Meyer RL, Ingmer H, Poulsen TB, Torring T. | Microbiol Spectr | 10.1128/spectrum.00625-23 | 2023 | | |
| Pathogenicity | Directing Drugs to Bugs: Antibiotic-Carbohydrate Conjugates Targeting Biofilm-Associated Lectins of Pseudomonas aeruginosa. | Meiers J, Zahorska E, Rohrig T, Hauck D, Wagner S, Titz A. | J Med Chem | 10.1021/acs.jmedchem.0c00856 | 2020 | |
| Proof-of-Concept Standardized Approach Using a Single-Disk Method Analogous to Antibiotic Disk Diffusion Assays for Routine Phage Susceptibility Testing in Diagnostic Laboratories. | Skusa R, Gross J, Kohlen J, Schafmayer C, Ekat K, Podbielski A, Warnke P. | Appl Environ Microbiol | 10.1128/aem.00309-22 | 2022 | | |
| Expanding the antibacterial selectivity of polyether ionophore antibiotics through diversity-focused semisynthesis. | Lin S, Liu H, Svenningsen EB, Wollesen M, Jacobsen KM, Andersen FD, Moyano-Villameriel J, Pedersen CN, Norby P, Torring T, Poulsen TB. | Nat Chem | 10.1038/s41557-020-00601-1 | 2021 | | |
| Pathogenicity | High-resolution taxonomic examination of the oral microbiome after oil pulling with standardized sunflower seed oil and healthy participants: a pilot study. | Griessl T, Zechel-Gran S, Olejniczak S, Weigel M, Hain T, Domann E. | Clin Oral Investig | 10.1007/s00784-020-03582-0 | 2021 | |
| Metabolism | Acyl Histidines: New N-Acyl Amides from Legionella pneumophila. | Torring T, Shames SR, Cho W, Roy CR, Crawford JM. | Chembiochem | 10.1002/cbic.201600618 | 2017 | |
| Phylogeny | A rapid culture independent methodology to quantitatively detect and identify common human bacterial pathogens associated with contaminated high purity water. | Minogue E, Tuite NL, Smith CJ, Reddington K, Barry T. | BMC Biotechnol | 10.1186/s12896-015-0124-1 | 2015 | |
| Insights into the Antimicrobial Activities and Metabolomes of Aquimarina (Flavobacteriaceae, Bacteroidetes) Species from the Rare Marine Biosphere. | Silva SG, Paula P, da Silva JP, Mil-Homens D, Teixeira MC, Fialho AM, Costa R, Keller-Costa T. | Mar Drugs | 10.3390/md20070423 | 2022 | | |
| Metabolism | Novel Antimicrobial Peptides EeCentrocins 1, 2 and EeStrongylocin 2 from the Edible Sea Urchin Echinus esculentus Have 6-Br-Trp Post-Translational Modifications. | Solstad RG, Li C, Isaksson J, Johansen J, Svenson J, Stensvag K, Haug T. | PLoS One | 10.1371/journal.pone.0151820 | 2016 | |
| Pathogenicity | Characterization and in vitro testing of newly isolated lytic bacteriophages for the biocontrol of Pseudomonas aeruginosa. | Harada LK, Silva EC, Rossi FP, Cieza B, Oliveira TJ, Pereira C, Tomazetto G, Silva BB, Squina FM, Vila MM, Setubal JC, Ha T, da Silva AM, Balcao VM | Future Microbiol | 10.2217/fmb-2021-0027 | 2022 | |
How to citeIf you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive12795.20251217.10
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data
License